FHC
AGIO icon

First Horizon Corporation’s Agios Pharmaceuticals AGIO Stock Holding History

First Horizon Corporation’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4K Sell
442
-201
-31% -$6.1K ﹤0.01% 1003
2026
Q1 		$21.8K Sell
643
-2,452
-79% -$69.5K ﹤0.01% 873
2025
Q4 		$84.2K Buy
3,095
+1,971
+175% +$69.2K ﹤0.01% 549
2025
Q3 		$45.1K Buy
+1,124
New +$42.3K ﹤0.01% 637

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

First Horizon Corporation's AGIO Position: Q2 2026 in Review

First Horizon Corporation reduced its Agios Pharmaceuticals (AGIO) stake by 31% in Q2 2026, selling an estimated $6.1K and leaving 442 shares worth $16.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1003.

First Horizon Corporation first reported a position in AGIO in Q3 2025 and has held it in 4 quarters since. The position peaked at $84.2K in Q4 2025. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • First Horizon Corporation held 442 shares of Agios Pharmaceuticals worth $16.4K as of Q2 2026.
  • First Horizon Corporation sold 201 Agios Pharmaceuticals shares in Q2 2026, an estimated $6.1K.
  • Agios Pharmaceuticals made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #1003 holding.
  • First Horizon Corporation first reported a position in Agios Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • First Horizon Corporation's Agios Pharmaceuticals position peaked at $84.2K in Q4 2025.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.